Exploration of novel biomarkers for hypertensive disorders of pregnancy by comprehensive analysis of peptide fragments in blood: their potential and technologies supporting quantification

What is it about?

Hypertensive disorders of pregnancy (HDP) are one of the most important pregnancy complications. The pathogenesis of HDP is complex, and new disease biomarkers (DBMs) are needed to serve as indicators of disease activity. In this paper, among the currently proposed DBM candidates, we introduce a study focusing on peptide fragments in blood identified by a comprehensive quantitative method, and suggest the ideal direction of the study.

Featured Image